|
2009
|
Invention
|
A marker for graft failure and mortality. Subject of the present invention is a biomarker for gra... |
|
|
Invention
|
Pro-endothelin-1 for the prediction of impaired peak oxygen consumption. Subject of the present i... |
|
|
Invention
|
Pro-endothelin-1 levels for the prediction of risk of tachyarrhytmic events.
The invention relat... |
|
|
Invention
|
Use of procalcitonin (pct) in prognosis following acute coronary syndromes.
Subject of the prese... |
|
|
Invention
|
Use of procalcitonin (pct) in prognosis following acute coronary syndromes. Subject of the presen... |
|
|
Invention
|
Method for the identification of patients in need of therapy having minor cognitive disorders and... |
|
2008
|
Invention
|
Method for risk stratification in stable coronary artery disease. In vitro method for the risk st... |
|
|
Invention
|
Use of procalcitonin (pct) in risk stratification and prognosis of patients with a primary, non-i... |
|
|
Invention
|
Method for detecting analytes. The present invention relates to a method for detecting analytes o... |
|
|
Invention
|
Method and agent for the prevention, inhibition and treatment of sepsis.
The invention relates t... |
|
|
Invention
|
Diagnosis and risk stratification using nt-proet-1. The invention relates to a method for the dia... |
|
|
Invention
|
Method for determining amino-terminal proanp in patients having a cardiac disease or being suspec... |
|
|
Invention
|
Diagnosis and risk stratification of cardiac insufficiency by means of natriuretic peptides for n... |
|
|
Invention
|
Uses of carbamoyl phosphate synthetase 1 (cps 1) and it's fragments for the diagnosis of liver di... |
|
|
Invention
|
Method for the selective determination of procalcitonin 1-116 for diagnostic purposes and antibod... |
|
2007
|
Invention
|
Diagnosis and risk classification of acute coronary syndrome by means of ct-proet-1 in combinatio... |
|
|
Invention
|
Diagnosis and risk stratification by means of the novel marker ct-proadm. The invention relates t... |
|
|
Invention
|
Diagnosis and risk stratification of cardiac insufficiency using neurophysin. The invention relat... |
|
|
Invention
|
In vitro method for the diagnosis and early diagnosis of neurodegenerative disorders. In vitro me... |
|
|
Invention
|
Diagnosis and risk stratification of infections and chronic diseases of the respiratory tract and... |
|
|
Invention
|
Diagnosis and risk assessment of pancreatic diabetes using mr-proadm. The invention relates to a ... |
|
|
Invention
|
Risk stratification for acute coronary syndrome by means of fragments/partial peptides of provaso... |
|
|
Invention
|
Diagnosis of infections or inflammatory diseases of the airways and lungs associated with heart f... |
|
|
Invention
|
Method for controlling the therapy of patients suffering from cardiac insufficiency by means of i... |
|
|
Invention
|
In vitro multiparameter determination method for the diagnosis and early diagnosis of neurodegene... |
|
|
Invention
|
In vitro procedure for diagnosis and early diagnosis of neurodegenerative diseases. An in vitro p... |
|
|
Invention
|
In vitro method for the identification and early identification and for the concomitant monitorin... |
|
2006
|
Invention
|
In vitro method for diagnosing neurodegenerative diseases.
Disclosed is an in vitro method for t... |
|
|
Invention
|
In vitro method for diagnosing neurodegenerative diseases. Disclosed is an in vitro method for de... |
|
|
Invention
|
Method for enhancing the performance and general condition of a subject |
|
|
Invention
|
In vitro process for diagnosticating neurogenerative diseases. The invention relates to a method ... |
|
|
Invention
|
Csf diagnostic in vitro method for diagnosis of dementia and neuroinflammatory diseases. CSF diag... |
|
|
Invention
|
Determination of short-chain srl-alcohol dehydrogenase (dhrs4) as biomarker of inflammations and ... |
|
2005
|
Invention
|
Methods for the diagnosis and treatment of critically ill patients with endothelin, endothelin ag... |
|
|
Invention
|
Identifying gastrokine 1 (gkn1) as a biomarker for inflammations and infections. The invention re... |
|
|
Invention
|
Uses of carbamoyl phosphate synthetase 1 (cps 1) as a humoral biomarker for the diagnosis of tumo... |
|
|
Invention
|
Diagnostic method for disorders using copeptin. The use of copeptin as diagnostic marker for the ... |
|
|
Invention
|
Novel monoclonal thyroid stimulating or blocking antibodies, peptide sequences corresponding thei... |
|
|
Invention
|
Method for detecting the formation of endothelins for medical diagnosis, and antibodies and kits ... |
|
|
Invention
|
Diagnosis of sepsis by the selective determination of the concentration of cu/zn superoxide dismu... |
|
2004
|
Invention
|
Method for the diagnosis of diseases by determining apolipoprotein ci. A method for the diagnosis... |
|
|
Invention
|
Identifying a midregional proadrenomedullin partial peptide in biological liquids for diagnostic ... |
|
2003
|
Invention
|
Identification of tsh receptor autoantibodies using affinity-purified antibodies. The invention r... |
|
|
Invention
|
Sandwich immunoassay for identifying partial proanp peptides. Disclosed is an improved sandwich i... |
|
|
Invention
|
Method and agents for the prevention, inhibition and therapy of cancers.
Disclosed are uses of G... |
|
|
Invention
|
Method for diagnosing sepsis by determining anti-asialogangliside antibodies.
The invention rela... |
|
|
Invention
|
Method for diagnosing sepsis by determining anti-asialoganglioside antibodies. The invention rela... |
|
|
Invention
|
Method and agent for the prevention, inhibition and treatment of sepsis. The invention relates to... |
